Skip Navigation

A Phase I Study Evaluating BAFFR-targeting CAR T cells for Patients with Relapsed or Refractory B-cell Non-Hodgkin?s Lymphoma B-NHL

Brief Summary

Type:
Lymphomas

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT05370430

Study #:
STUDY00161390

Start Date:
Oct 27, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05370430

View Complete Trial Details & Eligibility at ClinicalTrials.gov